GEMFIBROZIL
- Product NDC
- 61919-968
- 11-digit product format
- 619190968
- Labeler code
- 61919
- Product ID
- 61919-968_9c9436ae-7de7-1c16-e053-2a95a90a3238
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GEMFIBROZIL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA077836
- Marketing category
- ANDA
- Marketing start
- 2015-12-03
- Marketing end
- 0000-00-00
- Substance
- GEMFIBROZIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-968-60 | GEMFIBROZIL | 60 in 1 BOTTLE | TABLET | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-968 | GEMFIBROZIL TABLET [DIRECTRX] | 2 | Legacy NDC, 1 package rows | 20200131_261817da-b8d6-2b32-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-968-60 | 61919096860 | 60 TABLET in 1 BOTTLE (61919-968-60) | 60 tablet | 2015-12-03 | 0000-00-00 | No | No | Current |